Published in Mech Dev on October 01, 2001
The Arabidopsis basic/helix-loop-helix transcription factor family. Plant Cell (2003) 5.68
Specification of neuronal identities by feedforward combinatorial coding. PLoS Biol (2007) 2.19
Origin and diversification of the basic helix-loop-helix gene family in metazoans: insights from comparative genomics. BMC Evol Biol (2007) 1.98
Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol Cell Biol (2006) 1.86
Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front Neuroendocrinol (2010) 1.25
A short receptor downregulates JAK/STAT signalling to control the Drosophila cellular immune response. PLoS Biol (2010) 1.20
The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers. Mol Cell Biol (2002) 1.19
Early B-cell factors are required for specifying multiple retinal cell types and subtypes from postmitotic precursors. J Neurosci (2010) 1.02
The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function. Immunol Rev (2014) 1.02
The ancestral role of COE genes may have been in chemoreception: evidence from the development of the sea anemone, Nematostella vectensis (Phylum Cnidaria; Class Anthozoa). Dev Genes Evol (2004) 1.01
Nodal points and complexity of Notch-Ras signal integration. Proc Natl Acad Sci U S A (2009) 0.99
Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps. Development (2011) 0.95
The doublesex-related gene, XDmrt4, is required for neurogenesis in the olfactory system. Proc Natl Acad Sci U S A (2005) 0.95
Inhibition of p300/CBP by early B-cell factor. Mol Cell Biol (2003) 0.94
unc-3-dependent repression of specific motor neuron fates in Caenorhabditis elegans. Dev Biol (2008) 0.91
The metazoan history of the COE transcription factors. Selection of a variant HLH motif by mandatory inclusion of a duplicated exon in vertebrates. BMC Evol Biol (2008) 0.89
Pattern formation during development of the embryonic cerebellum. Front Neuroanat (2012) 0.88
EBF proteins participate in transcriptional regulation of Xenopus muscle development. Dev Biol (2011) 0.87
Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. Cell Death Differ (2010) 0.87
Retinoic acid influences anteroposterior positioning of epidermal sensory neurons and their gene expression in a developing chordate (amphioxus). Proc Natl Acad Sci U S A (2004) 0.86
BM88/CEND1 coordinates cell cycle exit and differentiation of neuronal precursors. Proc Natl Acad Sci U S A (2007) 0.86
The origin and evolution of the ectodermal placodes. J Anat (2012) 0.86
EBF factors drive expression of multiple classes of target genes governing neuronal development. Neural Dev (2011) 0.84
Coe genes are expressed in differentiating neurons in the central nervous system of protostomes. PLoS One (2011) 0.84
Early B-cell factors 2 and 3 (EBF2/3) regulate early migration of Cajal-Retzius cells from the cortical hem. Dev Biol (2012) 0.84
Inhibition of the nuclear import of cubitus interruptus by roadkill in the presence of strong hedgehog signal. PLoS One (2010) 0.84
EBF2 transcriptionally regulates brown adipogenesis via the histone reader DPF3 and the BAF chromatin remodeling complex. Genes Dev (2017) 0.84
Structural determination of functional domains in early B-cell factor (EBF) family of transcription factors reveals similarities to Rel DNA-binding proteins and a novel dimerization motif. J Biol Chem (2010) 0.81
A genome-wide identification and analysis of the basic helix-loop-helix transcription factors in the ponerine ant, Harpegnathos saltator. BMC Evol Biol (2012) 0.80
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma. Proc Natl Acad Sci U S A (2010) 0.80
Expression of collier in the premandibular segment of myriapods: support for the traditional Atelocerata concept or a case of convergence? BMC Evol Biol (2011) 0.79
Novel de novo variant in EBF3 is likely to impact DNA binding in a patient with a neurodevelopmental disorder and expanded phenotypes: patient report, in silico functional assessment, and review of published cases. Cold Spring Harb Mol Case Stud (2017) 0.78
Genome-Wide Mapping of Collier In Vivo Binding Sites Highlights Its Hierarchical Position in Different Transcription Regulatory Networks. PLoS One (2015) 0.77
Conservation and divergence of bHLH genes in the calcisponge Sycon ciliatum. Evodevo (2016) 0.77
The effect of RA on the chick Ebf1-3 genes expression in somites and pharyngeal arches. Dev Genes Evol (2014) 0.76
ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. Biomed Res Int (2015) 0.76
Genome-wide identification and analysis of basic helix-loop-helix domains in dog, Canis lupus familiaris. Mol Genet Genomics (2014) 0.75
Genetic dissection of the Transcription Factor code controlling serial specification of muscle identities in Drosophila. Elife (2016) 0.75
An RNAi-based approach to down-regulate a gene family in vivo. PLoS One (2013) 0.75
The Transcription Factors EBF1 and EBF2 Are Positive Regulators of Myelination in Schwann Cells. Mol Neurobiol (2016) 0.75
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A (1992) 3.71
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med (2001) 3.26
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96
Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol (1995) 2.79
Sequence and structure of the serendipity locus of Drosophila melanogaster. A densely transcribed region including a blastoderm-specific gene. J Mol Biol (1985) 2.58
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology (2007) 2.55
A Drosophila Minute gene encodes a ribosomal protein. Nature (1985) 2.53
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
ovo/svb integrates Wingless and DER pathways to control epidermis differentiation. Nature (1999) 2.32
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet (1991) 2.28
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry (2008) 2.16
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Mutations in eukaryotic 18S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics. EMBO J (1994) 2.08
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Cricoid pressure: can protective force be sustained? Br J Anaesth (1998) 1.97
Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology (2011) 1.93
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Clinical aspects of MuSK antibody positive seronegative MG. Neurology (2003) 1.89
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child (2009) 1.84
Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science (1991) 1.82
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol (1982) 1.78
NMO-IgG in the diagnosis of neuromyelitis optica. Neurology (2007) 1.77
Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature (1985) 1.76
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74
TFIIIA and homologous genes. The 'finger' proteins. Nucleic Acids Res (1986) 1.74
Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol (2004) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet (1994) 1.69
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect (2011) 1.57
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci (1997) 1.56
Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev (1980) 1.54
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol (1997) 1.50
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1995) 1.49
Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. J Antimicrob Chemother (1997) 1.48
Trans-activation of the 5' to 3' viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. C R Acad Sci III (1993) 1.42
The COE transcription factor Collier is a mediator of short-range Hedgehog-induced patterning of the Drosophila wing. Curr Biol (1999) 1.39
Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol (1987) 1.38
Comparisons of proteins associated with duck-globin mRNA and its polyadenylated segment in polyribosomal and repressed free messenger ribonucleoprotein complexes. Eur J Biochem (1981) 1.37
Collier, a novel regulator of Drosophila head development, is expressed in a single mitotic domain. Curr Biol (1996) 1.36
AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology (2002) 1.35
The estrogen receptor locus is associated with a major gene influencing litter size in pigs. Proc Natl Acad Sci U S A (1996) 1.33
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1997) 1.33
Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol (1997) 1.33
Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. Clin Exp Immunol (1982) 1.32
Spontaneous healing of aneurysmal bone cysts. A report of three cases. J Bone Joint Surg Br (1989) 1.32
Male pregnancy in seahorses and pipefishes (family Syngnathidae): rapid diversification of paternal brood pouch morphology inferred from a molecular phylogeny. J Hered (2001) 1.32
Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology (2009) 1.30
The serendipity alpha gene encodes a membrane-associated protein required for the cellularization of the Drosophila embryo. Genes Dev (1990) 1.30
Development of innervation of skeletal muscle fibers in man: relation to acetylcholine receptors. Anat Rec (1993) 1.28
Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn (1997) 1.27
Limbic encephalitis in children and adolescents. Arch Dis Child (2010) 1.26
FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry (2010) 1.26
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology (2012) 1.25
Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol (2001) 1.25
Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol (2005) 1.24
Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology (1987) 1.24
Neuromuscular transmission after immunization against acetylcholine receptors. Proc R Soc Lond B Biol Sci (1975) 1.22
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry (2006) 1.22
Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet (1997) 1.22
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis. J Neuroimmunol (1996) 1.21
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet (1986) 1.20
Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry (1980) 1.20
Toward a physical map of the Xq28 region in man: linking color vision, G6PD, and coagulation factor VIII genes to an X-Y homology region. Genomics (1989) 1.19
Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology (2011) 1.19
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology (2005) 1.18
Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology (1981) 1.17
Mother's little helpers: Patterns of male care in mammals. Trends Ecol Evol (1994) 1.17
XCoe2, a transcription factor of the Col/Olf-1/EBF family involved in the specification of primary neurons in Xenopus. Curr Biol (1998) 1.16
Requirement for the Drosophila COE transcription factor Collier in formation of an embryonic muscle: transcriptional response to notch signalling. Development (1999) 1.15
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology (2005) 1.14
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits. Eur J Biochem (1993) 1.14
Evidence for a translational inhibitor linked to globin mRNA in untranslated free cytoplasmic messenger ribonucleoprotein complexes. FEBS Lett (1976) 1.13
Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. Neurology (2003) 1.13
Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. Br J Clin Pharmacol (2000) 1.13
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics. Breast Cancer Res Treat (2011) 1.12
In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet (1978) 1.12
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci (1989) 1.12
Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain (1978) 1.11
A simple method for delivering morpholino antisense oligos into the cytoplasm of cells. Antisense Nucleic Acid Drug Dev (1996) 1.11
Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. Virology (2002) 1.10
Genetic mapping of the Xq27-q28 region: new RFLP markers useful for diagnostic applications in fragile-X and hemophilia-B families. Am J Hum Genet (1988) 1.10
Effects of pre- and postnatal stimulation on developmental, emotional, and cognitive aspects in rodents: a review. Dev Psychobiol (2002) 1.09
Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology (2000) 1.09
The translational repression of globin mRNA in free cytoplasmic ribonucleoprotein complexes. Eur J Biochem (1980) 1.09
The three dominant female-sterile mutations of the Drosophila ovo gene are point mutations that create new translation-initiator AUG codons. Development (1996) 1.09
Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology (2011) 1.08